Ginkgo Biloba
cognitive support and circulatory health
herbCirculatory herb for cognition, memory, and microvascular flow.
Quick answer
What it is: Ginkgo biloba is one of the oldest living tree species, with individual trees living as long as 2,500 years.
May support:Multiple Sclerosis (MS), Parkinson's Disease, Multiple Sclerosis, Asthma, Vitiligo, Brain Fog, ADHD
Evidence:Evidence · Grade D
Evidence Summary
Given the lack of specific PubMed studies provided, the rationale for any claims about Ginkgo biloba is based on general knowledge of the existing scientific literature, which includes a mix of in vitro studies, animal models, and human clinical trials. The overall evidence for many of its uses is often described as mixed or inconclusive, necessitating cautious language.
Last reviewed · Jun 2026
Have you tried Ginkgo Biloba?
Vote in 5 seconds. Add details if you want.
Your experience for Multiple Sclerosis (MS):
Commonly Combined With
Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.
Community signal breakdown
Where this remedy is being discussed across the web and community.
People Like Me insights
As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Community Discussions
What people say about Ginkgo Biloba
Latest News
Latest news on Ginkgo Biloba
Health Videos
Health videos on Ginkgo Biloba
Why It Works
How it works in more detail
How to use
Always consult a qualified clinician.Editorial guidance
- Anticoagulants (e.g., warfarin)
- Antiplatelet drugs (e.g., aspirin, clopidogrel)
- NSAIDs (e.g., ibuprofen, naproxen)
- SSRIs (selective serotonin reuptake inhibitors)
- Anticonvulsants
- Diabetes medications
- Bleeding disorders
- Taking anticoagulant/antiplatelet medications
- Epilepsy or seizure disorders
- Pregnancy
- Breastfeeding
Community tips
No community tips yet — be the first to share what worked for you.
Suggested dosage
General guidance — discuss specifics with a clinician.
Active medicinal compounds
Traditional use
Safety
Safety warnings
Avoid if
- Bleeding disorders
- Taking anticoagulant/antiplatelet medications
- Epilepsy or seizure disorders
- Pregnancy
- Breastfeeding
Medication interactions
- Anticoagulants (e.g., warfarin)
- Antiplatelet drugs (e.g., aspirin, clopidogrel)
- NSAIDs (e.g., ibuprofen, naproxen)
- SSRIs (selective serotonin reuptake inhibitors)
- Anticonvulsants
- Diabetes medications
Reported side effects
- Headache
- Dizziness
- Palpitations
- Gastrointestinal upset
- Constipation
- Allergic skin reactions
General guidance — discuss specifics with a clinician.
Evidence ecosystem
Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.
Overall grade (D)
Given the lack of specific PubMed studies provided, the rationale for any claims about Ginkgo biloba is based on general knowledge of the existing scientific literature, which includes a mix of in vitro studies, animal models, and human clinical trials. The overall evidence for many of its uses is often described as mixed or inconclusive, necessitating cautious language.
Filter by source type
Meta-Analyses(6)
Pooled analyses across multiple human trials.
Zhou P, Yu X, Song T, Hou X · PloS one · 2024 · n=650
To systematically evaluate the safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder (ADHD). Randomized controlled trials and prospective studies on antioxidant therapy in children and adolescents with ADHD were searched in PubMed, Embase, and Cochrane Library from the inception of databases to November 12, 2022. Two investigators independently screened the literature, extracted data, and evaluated the quality of the included studies. Network meta-analysis (PROSPERO registration number CRD 42023382824) was carried out by using R Studio 4.2.1. 48 studies involving 12 antioxidant drugs (resveratrol, pycnogenol, omega-3, omega-6, quercetin, phosphatidylserine, almond, vitamin D, zinc, folic acid, ginkgo biloba, Acetyl-L-carnitine) were finally included, with 3,650 patients. Network meta-analysis showed that omega-6 (0.18), vitamin D (0.19), and quercetin (0.24) were the top three safest drugs according to SUCRA. The omega-3
Meta-AnalysisPubMedVery High QualityThe Impact of Antioxidants on Vitiligo and Melasma: A Scoping Review and Meta-Analysis.
Speeckaert R, Bulat V, Speeckaert MM, van Geel N · Antioxidants (Basel, Switzerland) · 2023
Reactive oxygen species (ROS) generated during melanogenesis make melanocytes particularly vulnerable to oxidative stress, influencing their survival and melanin synthesis. Oxidative stress, significantly present in vitiligo and recently also detected in melasma, triggers inflammatory cascades and melanogenesis, making antioxidants a promising therapeutic avenue. A systematic search was conducted on Embase and Pubmed to study the efficacy of antioxidants for treating vitiligo and/or melasma. Meta-analysis was performed to assess the difference in Melasma Severity Index (MASI) scores between baseline and follow-up. Various antioxidants like polypodium leucotomos, ginkgo biloba, catalase/superoxide dismutase, and vitamin E have potential in vitiligo. For melasma, vitamin C, silymarin, and niacinamide were among those showing promise in reducing pigmentation, with vitamin C displaying significant effects in meta-analysis. Different antioxidants improve both vitiligo and melasma, with an i
Meta-AnalysisPubMedVery High QualityMedicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
Zhang W, Yan Y, Wu Y, Yang H, Zhu P, Yan F · Pharmacological research · 2022
Anxiety disorder is a common psychiatric illness. Medicinal herbs have become a field of interest in the treatment of anxiety. This study aimed to evaluate and compare the efficacy and acceptability of all possible medicinal herbs for the treatment of anxiety. A Bayesian network meta-analysis was conducted for adults with diagnosed or subthreshold anxiety in randomized controlled trials identified in PubMed, EMBASE, the Cochrane Library, and Web of Science, searched between Jan 1, 1987, and Dec 31, 2021. The outcomes included efficacy (measured by endpoint Hamilton Anxiety Scale [HAMA] Scores) and acceptability (discontinuation by ineffectiveness, worsening of the symptoms, or adverse events). A total of 29 trials were reviewed, comparing 12 medicinal herbs. Silexan (mean difference [MD]: -3.84, 95% credible interval [CrI]: -6.31 to -1.34) displayed a significant effect on anxiety, and possibly benefitted the treatment of depression (standard mean difference [SMD]: -0.37, 95% confide
Meta-AnalysisPubMedVery High Quality
Systematic Reviews(4)
Structured reviews of the full body of evidence (incl. Cochrane).
Golsorkhi H, Qorbani M, Sabbaghzadegan S, Dadmehr M · Avicenna journal of phytomedicine · 2023
This study was performed to provide an updated systematic review of herbal medicines and phytochemicals used for treatment of the pediatric patients with attention- deficit/hyperactivity disorder (ADHD). International electronic databases, including Scopus, PubMed, ScienceDirect, and Google Scholar were investigated from 1st January 2000 to late October 2021. Interventional studies published in English language, including randomized controlled trials (RCTs) or open-label clinical studies, which evaluated the effect of herbal medicines and phytochemicals on pediatric ADHD were included in this review. Fifteen studies met the inclusion criteria. Several pieces of evidence support the efficacy of Ginkgo biloba L. and Pycnogenol; mainly inconclusive evidence could be found for Valeriana officinalis L., Melissa officinalis L., and ginseng. The results showed that while Hypericum perforatum L. was ineffective for ADHD, Passiflora incarnata L., Crocus sativus L, and Prunus dulcis (Mill.) D.
Systematic ReviewPubMedVery High QualityPlant-derived nootropics and human cognition: A systematic review.
Lorca C, Mulet M, Arévalo-Caro C, Sanchez MÁ, Perez A, Perrino M · Critical reviews in food science and nutrition · 2023
Substances with modulatory capabilities on certain aspects of human cognition have been revered as nootropics from the dawn of time. The plant kingdom provides most of the currently available nootropics of natural origin. Here, in this systematic review, we aim to provide state-of-the-art information regarding proven and unproven effects of plant-derived nootropics (PDNs) on human cognition in conditions of health and disease. Six independent searches, one for each neurocognitive domain (NCD), were performed in parallel using three independent scientific library databases: PubMed, Cochrane and Scopus. Only scientific studies and systematic reviews with humans published between January 2000 and November 2021 were reviewed, and 256 papers were included. Ginkgo biloba was the most relevant nootropic regarding perceptual and motor functions. Bacopa monnieri improves language, learning and memory. Withania somnifera (Ashwagandha) modulates anxiety and social-related cognitions. Caffeine enh
Systematic ReviewPubMedVery High QualityHerbal medicines in the treatment of psychiatric disorders: 10-year updated review.
Sarris J · Phytotherapy research : PTR · 2018
This paper provides a 10-year update of the 2007 systematic review of herbal medicines studied in a broad range of psychiatric disorders, including depression, anxiety, obsessive-compulsive, seasonal affective, bipolar, psychotic, phobic, somatoform, and attention-deficit hyperactivity disorders. Ovid Medline, PubMed, and the Cochrane Library were searched for herbal medicines with both pharmacological and clinical evidence of psychotropic activity. This updated review now covers clinical trial evidence for 24 herbal medicines in 11 psychiatric disorders. High-quality evidence was found to exist for the use of Piper methysticum (Kava), Passiflora spp. (passionflower) and Galphimia glauca (galphimia) for anxiety disorders; and Hypericum perforatum (St John's wort) and Crocus sativus (saffron) for major depressive disorder. Other encouraging herbal medicines with preliminary evidence include Curcuma longa (turmeric) in depression, Withania somnifera (ashwagandha) in affective disorders,
Systematic ReviewPubMedVery High Quality
Observational Studies(3)
Cohort, case-control, and cross-sectional human studies.
Akanchise T, Angelova A · Antioxidants (Basel, Switzerland) · 2023
Long-term neurological complications, persisting in patients who cannot fully recover several months after severe SARS-CoV-2 coronavirus infection, are referred to as neurological sequelae of the long COVID syndrome. Among the numerous clinical post-acute COVID-19 symptoms, neurological and psychiatric manifestations comprise prolonged fatigue, "brain fog", memory deficits, headache, ageusia, anosmia, myalgias, cognitive impairments, anxiety, and depression lasting several months. Considering that neurons are highly vulnerable to inflammatory and oxidative stress damages following the overproduction of reactive oxygen species (ROS), neuroinflammation and oxidative stress have been suggested to dominate the pathophysiological mechanisms of the long COVID syndrome. It is emphasized that mitochondrial dysfunction and oxidative stress damages are crucial for the pathogenesis of neurodegenerative disorders. Importantly, antioxidant therapies have the potential to slow down and prevent disea
Observational StudyPubMedLow QualityAlternative Systemic Treatments for Vitiligo: A Review.
Cohen BE, Elbuluk N, Mu EW, Orlow SJ · American journal of clinical dermatology · 2015
Vitiligo is a common, acquired disorder of skin pigmentation that can significantly impact quality of life. It often represents a therapeutic challenge, which has resulted in interest in alternative treatments such as herbal and vitamin supplements. In this review, we provide an overview of the most commonly studied complementary agents, describe proposed mechanisms of action, identify potential adverse effects, and discuss the primary evidence supporting their use. Our discussion focuses on L-phenylalanine, Polypodium leucotomos, khellin, Ginkgo biloba, and vitamins and minerals, including vitamins B12, C, and E, folic acid, and zinc used as monotherapy or in combination with other treatments for the management of vitiligo.
Observational StudyPubMedLow QualityJarema M · Neuro endocrinology letters · 2008
Herbal drug treatment has been known for centuries as a part of traditional medicine. Nowadays, it is still considered a useful and natural way to treat several medical conditions, including mental disturbances. The most frequently treated mental conditions include mood disorders (mainly depression), anxiety disorders, somatoform disorders, age-related cognitive decline, and sometimes psychotic disorders. Some herbal formulations, such as St. John's wort, have been analyzed in clinical trials to estimate their real value. The use of other herbal medicines, such as Kava-kava, valerian, and Ginkgo biloba is discussed.
Observational StudyPubMedLow Quality
Limitations: A significant limitation in the current understanding of Ginkgo biloba's efficacy is the variability in study designs, dosages, and the specific extracts used. Many studies have small sample sizes or short durations. Furthermore, some studies have shown conflicting results, and the clinical significance of observed effects is not always clear. There is a need for more large-scale, long-term, well-controlled clinical trials using standardized extracts.
This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.
Tried Ginkgo Biloba?
Help others see what actually works.
Tried Ginkgo Biloba?
Real-world results help others choose what's worth trying.